These exams were evaluated by the gastroenterology service, who asked for viral markers and autoimmune tests antinuclear antibodies and anti-smooth muscle antibody, the results of which were negative. Afterwards, the causal relationship between the clinical profile and flutamide was established and the medication was suspended after approximately 730 days of treatment.
Durante su estancia hospitalaria desarrolla ictericia y elevación de transaminasas, es valorado por el servicio de gastroenterología que solicita marcadores virales y pruebas autoinmunes anticuerpos antinucleares y anticuerpo antimúsculo liso, que fueron negativos; se establece la relación causal del cuadro clínico con la flutamida, entonces se suspende el fármaco tras aproximadamente 730 días de tratamiento.